Lv7
5000 积分 2023-07-31 加入
Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptors
21天前
已完结
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical development
1个月前
已完结
The preclinical discovery and development of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
1个月前
已完结
A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins
1个月前
已完结
Clinical Pharmacology Insights for Small Molecule and Antibody‐Based Drug Products Approved for Multiple Immune‐Mediated Indications
2个月前
已完结
Tu1453 A PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF P40XTL1A BISPECIFIC ANTIBODY PF-07261271 IN HEALTHY PARTICIPANTS
2个月前
已关闭
Assessing the clinical progress of the bispecific nanobody sonelokimab
3个月前
已完结
Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease
6个月前
已完结
Predicting Human Bioavailability of Subcutaneously Administered Monoclonal Antibodies Using Non-human Primate Linear Clearance and Antibody Isoelectric Point
8个月前
已完结
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
8个月前
已完结
皖公网安备34019202002308
